Quantcast

Latest Clinical trial Stories

2014-06-12 12:27:16

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/wilms_tumor_nephroblastoma_global_clinical_trials_review.html Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1,...

2014-06-12 08:35:19

Research Accepted as Podium Presentation at the American Diabetes Association 74th Scientific Sessions BOWIE, Md., June 12, 2014 /PRNewswire/ -- Inovalon, Inc., a leading technology company providing advanced cloud-based analytics and data-driven solutions to the healthcare industry, today announced a comparative safety research study to be presented at the American Diabetes Association 74(th) Scientific Sessions June 13-17 in San Francisco, California. The study was supported by...

2014-06-12 08:28:44

WCCT Global to Attend the 2014 DIA Meeting in San Diego COSTA MESA, Calif., June 12, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a Southern California headquartered Full Service Contract Research Organization announced today that the organization will be attending the 2014 DIA meeting in San Diego, California. WCCT Global will be an exhibitor at booth #821. WCCTG will be sharing information about many of the exciting clinical research services the company has both added and...

2014-06-12 08:28:37

SANTA ROSA, Calif., June 12, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, is pleased to announce today that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application without a clinical hold to begin human clinical testing of RUT58-60. Ruthigen...

2014-06-12 00:22:01

Both doses of investigational drug sarilumab met all three co-primary endpoints PARIS and TARRYTOWN, N.Y., June 12, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today presented positive results from a phase 3 trial of investigational drug sarilumab in rheumatoid arthritis (RA) patients who were inadequate responders to methotrexate (MTX) therapy. New data presented at the meeting showed that sarilumab increased major clinical...

2014-06-11 23:03:30

Panelists will offer insights into their story selection process and areas of interest. Washington (PRWEB) June 11, 2014 Reporters covering various aspects of the drug and medical device development industry will share their experiences during a Reporters Round Table on June 17 at 8 a.m. at the DIA 2014 50th Annual Meeting, in Room 16B at the San Diego Convention Center. Panelists will offer insights into their story selection process and areas of interest. This is a unique opportunity...

2014-06-11 23:02:03

Innovator to join Organovo CEO in session about breakthrough technology. WASHINGTON (PRWEB) June 11, 2014 In an era in which clinical studies take years to complete and testing a single drug can cost millions, technology that once seemed far-fetched — growing models of human organs on microchip — is making remarkable strides. Creating models of human organs on microchips can save the industry time and money and reduce the need for testing on animals and even patients themselves....

2014-06-11 12:29:22

WASHINGTON, June 11, 2014 /PRNewswire/ -- mProve Health's Trial Guide app takes off across numerous studies and is localized for more than 30 countries. As smartphone penetration tops 65% in many developed countries, more and more Sponsors are seeing the benefit of offering a customized Study App to their patients, not only in the US, but internationally. After all, most people have their phone within an arm's length 19 hours a day, and smartphone users often look at their phones more...

2014-06-11 08:30:11

James Sergi brings extensive experience to LifeSciences, which provides innovative solutions for reducing time to market, developments costs, and resources of new drugs and devices. GLEN BURNIE, Md., June 11, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's LifeSciences division. This entity was created to complement our other service offerings by providing guidance and...

2014-06-11 08:30:04

Seattle Children's Research Institute and Kineta Launch the Alliance for Children's Therapeutics SEATTLE, June 11, 2014 /PRNewswire/ -- Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related